Vanguard Investments Australia, Ltd.
Position in LAB — Standard Biotools Inc.
CIK 1550100
Victoria, C3
Position in LAB
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$48,717
New position
Shares Held
52,954
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Medical Devices
Healthcare · as of Mar 31, 2026Vanguard Investments Australia, Ltd. holds $346,694,500 across 42 Medical Devices names. LAB ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
867,077 | $89,022,795 | |
| 2 | SYK |
Stryker Corp
|
171,449 | $56,336,426 | |
| 3 | MDT |
Medtronic plc
|
638,521 | $55,327,844 | |
| 4 | BSX |
Boston Scientific Corp
|
737,743 | $46,293,373 | |
| 5 | EW |
Edwards Lifesciences Corp
|
288,789 | $23,126,223 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
228,279 | $16,248,899 | |
| 7 | DXCM |
Dexcom Inc
|
194,170 | $12,193,876 | |
| 8 | STE |
STERIS plc
|
48,958 | $10,826,082 |
All Filings in LAB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,717 | 52,954 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||